Rating History for Pandion Therapeutics (PAND) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/26/2021 | Geoffrey Porges | Downgrade | Market Perform (Outperform) |
60.00 (24.00) |
25.63 (60.05) |
134.3% | Details |
 |
|||||||
